SCHEDULE: Vesey Street Capital Partners Boosts AirSculpt Stake

A Schedule 13G filing reveals significant beneficial ownership of AirSculpt Technologies, Inc. common stock by entities associated with Vesey Street Capital Partners.

Summary

• This filing is an amendment to a Schedule 13G, indicating a change in beneficial ownership of AirSculpt Technologies, Inc. common stock.
• Several reporting persons, including EBS Aggregator Blocker Holdings, LLC, Adam T. Feinstein, VSCP EBS Aggregator, L.P., Vesey Street Capital Partners Healthcare Fund-A, L.P., and Vesey Street Capital Partners, L.L.C., are involved.
• Collectively, these entities hold a significant percentage of the company's outstanding shares.
• The filing details the number of shares beneficially owned, including sole and shared voting and dispositive power.
• A significant portion of shares are held directly by these entities, with additional shares subject to voting agreements.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive, indicating significant beneficial ownership by key investment entities, suggesting confidence in the company's future prospects.

Positives

• Adam T. Feinstein and associated entities collectively hold 42.1% of AirSculpt Technologies, Inc. common stock, indicating substantial investor confidence.
• The reporting persons have significant shared voting power (30,324,180 shares) and dispositive power (25,154,360 shares) over the company's stock.
• A specific agreement (Proxy and Voting Agreement) between Vesey Street Capital Partners and Thrivent White Rose Fund XI Equity Direct, L.P. outlines shared voting power over 5,169,820 shares, demonstrating coordinated investor strategy.
• The filing is an amendment, suggesting active management and potential strategic adjustments by significant stakeholders.

Negatives

• The filing does not detail the specific reasons for the increased beneficial ownership or any recent transactions that led to this filing.
• While voting power is shared, dispositive power over shares held by Thrivent White Rose Fund XI Equity Direct, L.P. is not held by Vesey and EBS Aggregator Blocker, creating a potential separation of voting and control.
• The 'blocker provision' mentioned in relation to Investor 1, Investor 3, and Investor 4 limits their ability to request share releases, potentially capping their direct ownership.

Risks

• The reliance on a Proxy and Voting Agreement for shared voting power over a significant block of shares could lead to disagreements or changes in voting alignment.
• The blocker provisions in various investor agreements limit the ability of certain investors to increase their direct ownership, potentially capping their influence.
• The assumption that Thrivent continued to hold all its shares, as stated in the filing, means actual ownership could differ if Thrivent has made dispositions.

Future Outlook

The filing does not contain specific forward-looking statements or guidance from the company. However, the significant stake held by reporting persons suggests a continued interest and potential influence on the company's future direction.

Management Comments

• Each of the Reporting Persons disclaims beneficial ownership of any securities that exceed their pecuniary interest therein.
• The Reporting Persons have not been furnished information regarding any disposition of such shares by Thrivent and, for purposes of this Schedule 13G, have assumed that Thrivent continued to hold all such shares as of the date of this Schedule 13G.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and investment firms accumulating significant stakes in publicly traded companies. This filing indicates active investment management within the medical aesthetics or related healthcare technology sector where AirSculpt Technologies operates.

Related Party Transactions

• The Proxy and Voting Agreement between Vesey Street Capital Partners, L.L.C. and Thrivent White Rose Fund XI Equity Direct, L.P. dated May 20, 2026, where Vesey is appointed proxy agent for Thrivent's shares.
• Various letter agreements dated October 27, 2021, as amended, between EBS Aggregator Blocker Holdings, LLC, Vesey Street Capital Partners, L.L.C., and other investors (Investor 1, Investor 2, Investor 3, Investor 4) outlining rights to request share releases.

Stakeholder Impact

• Shareholders: The significant stake and potential coordinated voting by reporting persons could influence corporate governance and strategic decisions, impacting shareholder value.
• Management: Increased influence from major shareholders may lead to greater scrutiny or pressure on management's performance and strategy.
• Investors (like Thrivent): While Thrivent has distributed shares, it retains a voting agreement with Vesey, indicating continued strategic alignment on certain matters.

Next Steps

• Monitoring of share ownership changes by the reporting persons.
• Observing any strategic decisions or actions taken by AirSculpt Technologies, Inc. that may be influenced by the significant stake held by Vesey Street Capital Partners and its affiliates.

Key Dates

Recommendation

The filing indicates a significant and potentially coordinated stake by institutional investors, suggesting a belief in the company's long-term value. However, without specific financial performance data or strategic initiatives detailed in this filing, a 'hold' recommendation is prudent, pending further information.

Keywords

AirSculpt Technologies, Schedule 13G, Beneficial Ownership, Vesey Street Capital Partners, EBS Aggregator Blocker Holdings, Adam T Feinstein, Common Stock, Voting Agreement